Evidence map›Paper›PMID 35972649›Full record

ArticleCellular and molecular life sciences : CMLS2022

Excess intracellular ATP causes neuropathic pain following spinal cord injury.

Nobuhiko Nakajima, Yuichiro Ohnishi, Masamichi Yamamoto, Daiki Setoyama, Hirohiko Imai, Tomofumi Takenaka, Mari Matsumoto, Koichi Hosomi, Yoichi Saitoh, Hidemasa Furue and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Purinergic Receptor P2Y2 Regulates Neurogenesis and Functional Recovery Following Spinal Cord Injury in Zebrafish.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  2. Article
  3. Review
  4. Potential Role ofGenes · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Nobuhiko Nakajima *Department of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yuichiro Ohnishi *Department of Research Promotion and Management, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. ohnishinsurg@gmail.com.ORCID http://orcid.org/0000-0003-3030-6230
Masamichi YamamotoDepartment of Research Promotion and Management, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan. yamamoto.mailserver@gmail.com.
Daiki SetoyamaDepartment of Clinical Chemistry and Laboratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Hirohiko ImaiDepartment of Systems Science, Graduate School of Informatics, Kyoto University, Kyoto, Japan.
Tomofumi TakenakaDepartment of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Mari MatsumotoDepartment of Research Promotion and Management, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shimmachi, Suita, Osaka, 564-8565, Japan.
Koichi HosomiDepartment of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Yoichi SaitohDepartment of Neuromodulation and Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
Hidemasa FurueDepartment of Neurophysiology, Hyogo College of Medicine, Hyogo, Japan.
Haruhiko KishimaDepartment of Neurosurgery, Graduate School of Medicine, Osaka University, Osaka, Japan.
The University of Osaka · JPNational Cerebral and Cardiovascular Center · JPHyogo Medical University · JPKyoto University · JPKyushu University · JPOsaka Neurological Institute · JP

Funding

Japan Agency for Medical Research and Development JP20ek0610017Japan Society for the Promotion of Science JP19K09527Japan Society for the Promotion of Science JP22K09248
6 · The paper itself

Abstract

Intractable neuropathic pain following spinal cord injury (NP-SCI) reduces a patient's quality of life. Excessive release of ATP into the extracellular space evokes neuroinflammation via purinergic receptor. Neuroinflammation plays an important role in the initiation and maintenance of NP. However, little is known about whether or not extracellular ATP cause NP-SCI. We found in the present study that excess of intracellular ATP at the lesion site evokes at-level NP-SCI. No significant differences in the body weight, locomotor function, or motor behaviors were found in groups that were negative and positive for at-level allodynia. The intracellular ATP level at the lesion site was significantly higher in the allodynia-positive mice than in the allodynia-negative mice. A metabolome analysis revealed that there were no significant differences in the ATP production or degradation between allodynia-negative and allodynia-positive mice. Dorsal horn neurons in allodynia mice were found to be inactivated in the resting state, suggesting that decreased ATP consumption due to neural inactivity leads to a build-up of intracellular ATP. In contrast to the findings in the resting state, mechanical stimulation increased the neural activity of dorsal horn and extracellular ATP release at lesion site. The forced production of intracellular ATP at the lesion site in non-allodynia mice induced allodynia. The inhibition of P2X4 receptors in allodynia mice reduced allodynia. These results suggest that an excess buildup of intracellular ATP in the resting state causes at-level NP-SCI as a result of the extracellular release of ATP with mechanical stimulation.

Indexed as

NeuralgiaSpinal Cord InjuriesAdenosine TriphosphateAnimalsHyperalgesiaMiceQuality of LifeSpinal CordSpinal Cord Dorsal HornAdenosine TriphosphateAstrocyteMicrogliaNeuroinflammationNeuropathic painPurinergic receptor

Identifiers

PMID35972649
PMCPMC11072579
OpenAlexW4292179595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.